Literature DB >> 8508696

Effect of erythromycin derivative EM523L on human interdigestive gastrointestinal tract.

O Kawamura1, T Sekiguchi, Z Itoh, S Omura.   

Abstract

We investigated the effect of an erythromycin derivative, EM523L, on interdigestive gastrointestinal motor activity and plasma motilin concentrations in three healthy volunteers using an infused catheter system. We administered doses of 500, 1000, and 2000 micrograms of EM523L to each subject as well as physiological saline. EM523L induced interdigestive migrating contractions (IMCs) that originated in the stomach and migrated to the duodenum. This response was noted in all three subjects after each dose of EM523L, while no IMCs were induced by saline. There were no significant differences in the characteristics of the EM523L-induced IMC and the spontaneous IMC. The initiation time, ie, the interval between the start of EM523L infusion and the onset of the IMC became shorter in a dose-dependent manner. Plasma motilin concentrations increased significantly after EM523L administration, suggesting that motilin is involved in the mechanism of IMC induction by this drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508696     DOI: 10.1007/BF01295717

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  12 in total

1.  The interdigestive myo-electric complex of the stomach and small bowel of dogs.

Authors:  C F Code; J A Marlett
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

2.  Erythromycin is a motilin receptor agonist.

Authors:  T Peeters; G Matthijs; I Depoortere; T Cachet; J Hoogmartens; G Vantrappen
Journal:  Am J Physiol       Date:  1989-09

3.  Macrolides with gastrointestinal motor stimulating activity.

Authors:  S Omura; K Tsuzuki; T Sunazuka; S Marui; H Toyoda; N Inatomi; Z Itoh
Journal:  J Med Chem       Date:  1987-11       Impact factor: 7.446

4.  Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 125I-motilin to duodenal muscle.

Authors:  Y Kondo; K Torii; Z Itoh; S Omura
Journal:  Biochem Biophys Res Commun       Date:  1988-01-29       Impact factor: 3.575

5.  Effect of erythromycin on interdigestive gastrointestinal contractile activity and plasma motilin concentration in humans.

Authors:  O Kawamura; T Sekiguchi; M Kusano; T Nishioka; Z Itoh
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

6.  Interdigestive phasic contractions of the human lower esophageal sphincter.

Authors:  J Dent; W J Dodds; T Sekiguchi; W J Hogan; R C Arndorfer
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

7.  Relationship between porcine motilin-induced migrating motor complex-like activity, vagal integrity, and endogenous motilin release in dogs.

Authors:  K E Hall; G R Greenberg; T Y El-Sharkawy; N E Diamant
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

8.  Erythromycin induces migrating motor complex in human gastrointestinal tract.

Authors:  T Tomomasa; T Kuroume; H Arai; K Wakabayashi; Z Itoh
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

9.  Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog.

Authors:  Z Itoh; M Nakaya; T Suzuki; H Arai; K Wakabayashi
Journal:  Am J Physiol       Date:  1984-12

10.  Heterogeneity of plasma motilin in patients with chronic renal failure.

Authors:  K Shima; S Shin; A Tanaka; E Hashimura; T Nishino; K Imagawa; Y Kumahara; N Yanaihara
Journal:  Horm Metab Res       Date:  1980-07       Impact factor: 2.936

View more
  5 in total

1.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs.

Authors:  T Tanaka; A Mizumoto; E Mochiki; H Suzuki; Z Itoh; S Omura
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.

Authors:  M J Veysey; P Malcolm; A I Mallet; P J Jenkins; G M Besser; G M Murphy; R H Dowling
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

5.  Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms.

Authors:  C Di Lorenzo; A F Flores; T Tomomasa; P E Hyman
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.